Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | MSCI World Private Equity Return Tracker |
| Investment focus | Equity, World |
| Fund size | EUR 9 m |
| Total expense ratio | 0.50% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | No |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | - |
| Inception/ Listing Date | 13 January 2026 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fondsaanbieder | Goldman Sachs |
| Fondsstructuur | Open-ended Investment Company (OEIC) |
| UCITS-conformiteit | Yes |
| Administrateur | BNY Mellon Fund Services (Ireland) DAC |
| Beleggingsadviseur | Goldman Sachs Asset Management International |
| Bewaarbank | The Bank of New York Mellon SA/NV, Dublin Branch |
| Revisiebedrijf | PricewaterhouseCoopers |
| Einde belastingjaar | 31 December |
| Vertegenwoordiger van Zwitserland | FIRST INDEPENDENT FUND SERVICES AG |
| Zwitserse uitbetalende instantie | Goldman Sachs Bank AG |
| Duitsland | Unknown |
| Zwitserland | Unknown |
| Oostenrijk | Unknown |
| UK | No UK Reporting |
| Indextype | - |
| Swap tegenpartij | - |
| Collateral manager | |
| Effectenlening | No |
| Tegenpartij die effecten uitleent |
| GE Vernova | 4.40% |
| Eli Lilly & Co. | 4.10% |
| Broadcom Inc. | 3.70% |
| Vertex Pharmaceuticals | 3.70% |
| Gilead Sciences, Inc. | 3.60% |
| Bristol Myers Squibb Co. | 3.40% |
| Palantir Technologies, Inc. | 3.30% |
| Microsoft | 3.20% |
| The Charles Schwab | 3.10% |
| Amphenol Corp. | 3.00% |
| United States | 89.00% |
| Other | 11.00% |
| Technology | 28.80% |
| Health Care | 20.60% |
| Financials | 13.00% |
| Industrials | 9.40% |
| Other | 28.20% |
| YTD | - |
| 1 maand | +2,03% |
| 3 maanden | - |
| 6 maanden | - |
| 1 jaar | - |
| 3 jaar | - |
| 5 jaar | - |
| Since inception | -0,58% |
| 2025 | - |
| 2024 | - |
| 2023 | - |
| 2022 | - |
| Volatiliteit 1 jaar | - |
| Volatiliteit 3 jaar | - |
| Volatiliteit 5 jaar | - |
| Rendement/Risico 1 jaar | - |
| Rendement/Risico 3 jaar | - |
| Rendement/Risico 5 jaar | - |
| Maximaal waardedaling 1 jaar | - |
| Maximaal waardedaling 3 jaar | - |
| Maximaal waardedaling 5 jaar | - |
| Maximaal waardedaling sinds aanvang | -3,72% |
| Beursnotering | Handelsvaluta | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| Borsa Italiana | EUR | GSPE | - - | - - | - |
| London Stock Exchange | GBP | GSPP | |||
| London Stock Exchange | USD | GSPE | |||
| SIX Swiss Exchange | CHF | GSPE | |||
| XETRA | EUR | GXPE |